Pre Clinical Lipid Nanoparticle Scientist (80 % FTE) University of Bern spinoff project Eldian Biomed - developer of the CloudLi platform

Pre Clinical Lipid Nanoparticle Scientist (80% FTE)
University of Bern spinoff project EldianBiomed - developer of the CloudLi platform

About EldianBiomed & CloudLi EldianBiomed is a spin off project based at the UniversityofBern’s Department of Chemistry, Biochemistry & PharmaceuticalSciences. Our flagship asset, CloudLi, is a lipid based nano and microparticle platform that lubricates articular cartilage and delivers peptides, proteins and small molecules directly to articular joints, aiming to revolutionise osteoarthritis treatment. Backed by an Innosuisse grant, we are building the pre clinical data package needed for first in human studies and building our preclinical pipeline.

The Opportunity

We’re seeking an energetic Pre Clinical Nanoparticle Scientist to drive formulation, analytics and in vivo work for CloudLi. You’ll work shoulder to shoulder with EldianBiomed’s founder and advisors, translating cutting edge research into a clinical candidate.
Preferred starting date: July 2025
Contract: 80% position funded until 31st December2026; strong likelihood of extension and equity participation after SeriesA financing (targetH12026).
Location: Bern, Switzerland (on site) with occasional travel to Zürich.

• Design and optimise liposomes/LNPs for treatment of joint diseases.
• Characterise particles (DLS, NTA, cryoTEM) and run stability assays (HPLC).
• Load peptides, proteins and small molecules.
• Partner with chemists on peptide design, SPPS and characterisation.
• Execute in vitro evaluations, ex vivo testing and rodent biodistribution studies.
• Perform tribological tests to quantify CloudLi mediated cartilage lubrication.
• Maintain lab infrastructure, author protocols, reports and IP relevant documentation.
• Present results to founders and advisers.

• PhD in Pharmaceutical Sciences, Nanomedicine, Biomedical Engineering, Chemistry or related field.
• Proven hands on experience with liposome/LNP formulation and analysis.
• Solid grounding in nano drug delivery, biopharmaceutics and analytical methods.
• Excellent English communication skills.
• Eagerness to thrive in a fast moving spin off environment and wear multiple hats.

• SPPS or peptide conjugation know how.
• Fluorescence microscopy, cell culture and rodent handling (FELASAB or willingness to obtain).
• Experience with tribometry.
• Familiarity with QbD/DoE, GLP/GMP and regulatory requirements.

• Immediate Impact - Your data will directly shape a first in class therapy.
• Agile & Visible - Flat hierarchy, rapid decisions and close interaction with the founder. Be one of the earliest employees on the spinoff project.
• Growth & Upside - Access to university core facilities, entrepreneurial training and future equity participation.
• Purpose Driven Culture - We value curiosity, transparency and scientific rigour.